Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
Inflammatory bowel diseases (IBDs) cause significant morbidity and mortality. Aberrant NF-κB signalling is strongly associated with these conditions, and several established drugs influence the NF-κB signalling network to exert their effect. This study aimed to identify drugs that alter NF-κB signal...
Sparad:
Huvudskapare: | , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Bok |
Publicerad: |
The Company of Biologists,
2020-11-01T00:00:00Z.
|
Ämnen: | |
Länkar: | Connect to this object online. |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
Signum: |
A1234.567 |
---|---|
Exemplar 1 | Tillgänglig |